Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women-Reference-Cited by-同舟云学术

Oral Lopinavir Use and Human Papillomavirus Infection in HIV-Positive Women

Published:2015-10-01 Issue:2 Volume:70 Page:e63-e66
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Lahiri Cecile D.,Dugan Katherine B.,Xie Xianhong,Reimers Laura,Burk Robert D.,Anastos Kathryn,Massad Leslie Stewart,Eltoum Isam-Eldin,Xue Xiaonan,D'Souza Gypsyamber,Flowers Lisa,Palefsky Joel M.,Rahangdale Lisa,Strickler Howard D.,Ofotokun Ighovwerha

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference26 articles.

1. . Global burden of human papillomavirus and related diseases.;Forman;Vaccine,2012

2. . Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.;Bosch;J Natl Cancer Inst,1995

3. . The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months.;Remmink;Int J Cancer,1995

4. . Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.;Walboomers;J Pathol,1999

5. . Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women.;Ahdieh;Am J Epidemiol,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topical therapies for the treatment of cervical intraepithelial neoplasia (CIN) 2–3: A narrative review;Gynecologic Oncology Reports;2020-08

2. An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia;Expert Opinion on Investigational Drugs;2015-10-12